JD.com steps into the GenAI realm with ChatRhino, a potent tool tailored for multiple sectors, synchronized with China’s fresh GenAI regulations.
JD.com, a giant in China’s e-commerce and logistics, recently introduced ChatRhino, their large language model, marking a significant stride in the GenAI sector. This move aligns closely with new interim laws in China aimed at regulating GenAI services. ChatRhino, also known as yanxi, is distinct in its structure, blending 70% general data with 30% specialized supply chain data, reflecting JD.com’s diverse business interests, including their logistics and healthcare units.
The prowess of ChatRhino is evident in its capacity to offer over 100 training and inference optimization tools. This empowers clients to swiftly develop domain-specific models, significantly reducing the time and manpower required traditionally. For instance, a GenAI model for healthcare can be constructed in mere minutes, a stark contrast to the usual week-long process.
Furthering its utility, JD Health has leveraged ChatRhino to create Jingyi Qianxun, a model trained for medical scenarios. This facilitates services like telemedicine, enhancing healthcare delivery. Additionally, e-commerce merchants can use ChatRhino to generate a variety of visuals and marketing materials efficiently, cutting down production costs and time remarkably.
Concurrently, China has introduced interim regulations to oversee the deployment of GenAI services. These laws, effective from August 15, aim to ensure the technology’s healthy development while protecting national security and public interests. The regulations require GenAI developers to adhere to legal standards in data sourcing and model optimization, emphasizing the need for accuracy, objectivity, and diversity in training data.
In summary, JD.com’s ChatRhino is a testament to the growing influence and necessity of GenAI in diverse sectors. Its launch under the new regulatory landscape of China underscores the critical balance between technological advancement and regulatory oversight.